Breaking News Instant updates and real-time market news.

OVV

Ovintiv

$39.91 /

-3.58 (-8.23%)

08:19
07/06/22
07/06
08:19
07/06/22
08:19

Ovintiv to sell portions of its Uinta, Bakken assets for $250M

Ovintiv announced it has reached agreements with two counterparties to sell portions of its assets located in the Uinta and Bakken Basins for total proceeds of approximately $250M. As a result of these agreements and continued strong financial and operational results, Ovintiv has elected to accelerate the doubling of its cash returns to shareholders. Starting immediately for the third quarter, Ovintiv will increase its returns to shareholders to 50% of the previous quarter's Non-GAAP Free Cash Flow after base dividends. The Uinta Basin assets being sold are mature waterflood assets with Operating Expenses of approximately $35.00 per BOE. The assets include approximately 3,000 gross vertical wells. Post the transaction, Ovintiv will retain approximately 130,000 largely contiguous net acres in the horizontal oil-rich shale portion of the play. The Bakken assets include approximately 88 wells, located mainly in Richland County, Montana, approximately 30 miles from Ovintiv's primary Bakken position. The agreements are subject to ordinary closing conditions, regulatory approvals and other adjustments and are expected to close in the third quarter. The effective date of both sales is April 1st, 2022. Total proceeds received are subject to customary closing adjustments. Ovintiv plans to update its 2022 production and Total Cost guidance to reflect the impact of the asset sales with its second quarter results. 2022 capital guidance will remain unchanged.

OTHER BREAKING NEWS FROM THE FLY

Syndicate
Vigil Neuroscience announces $75M private placement finanicng » 07:13
08/12/22
08/12
07:13
08/12/22
07:13
VIGL

Vigil Neuroscience

$7.29 /

+0.13 (+1.82%)

Vigil Neuroscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

02/01/22 Morgan Stanley
Morgan Stanley starts Vigil at Equal Weight ahead of 2023 derisking catalysts
02/01/22 Stifel
Stifel starts Vigil Neuroscience at Buy with $24 price target
02/01/22 Guggenheim
Vigil Neuroscience initiated with a Buy at Guggenheim
02/01/22 Stifel
Vigil Neuroscience initiated with a Buy at Stifel
VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

  • 07
    Jan
VIGL Vigil Neuroscience
$7.29 /

+0.13 (+1.82%)

Recommendations
Brilliant Earth price target raised to $10 from $8 at KeyBanc » 07:13
08/12/22
08/12
07:13
08/12/22
07:13
BRLT

Brilliant Earth

$6.44 /

-0.17 (-2.57%)

KeyBanc analyst Noah…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

07/22/22 Piper Sandler
Brilliant Earth downgraded to Neutral from Overweight at Piper Sandler
07/21/22 KeyBanc
KeyBanc transitions coverage of Global Brands & E-Commerce with cautious view
07/20/22 KeyBanc
Brilliant Earth initiated with an Overweight at KeyBanc
06/29/22 Raymond James
Brilliant Earth initiated with an Outperform at Raymond James
BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

  • 23
    Sep
BRLT Brilliant Earth
$6.44 /

-0.17 (-2.57%)

Earnings
Aslan Pharmaceuticals reports Q2 EPS (4c) vs (2c) last year » 07:12
08/12/22
08/12
07:12
08/12/22
07:12
ASLN

Aslan Pharmaceuticals

/

+

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASLN Aslan Pharmaceuticals
/

+

ASLN Aslan Pharmaceuticals
/

+

05/23/22 Piper Sandler
Aslan Pharmaceuticals price target lowered to $3 from $8 at Piper Sandler
09/27/21 Piper Sandler
Piper buyers on Aslan weakness, thinks ASLAN-004 can be competitive
ASLN Aslan Pharmaceuticals
/

+

Earnings
Gencor Industries reports Q3 EPS (7c) vs. 16c last year » 07:12
08/12/22
08/12
07:12
08/12/22
07:12
GENC

Gencor Industries

$9.57 /

-0.08 (-0.83%)

Reports Q3 revenue $29.6M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GENC Gencor Industries
$9.57 /

-0.08 (-0.83%)

GENC Gencor Industries
$9.57 /

-0.08 (-0.83%)

Recommendations
Chicken Soup for the Soul price target raised to $52 from $40 at DA Davidson » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
CSSE

Chicken Soup for the Soul

/

+

, RDBX

Redbox

$1.71 /

+ (+0.00%)

, ROKU

Roku

$80.65 /

-0.33 (-0.41%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSSE Chicken Soup for the Soul
/

+

RDBX Redbox
$1.71 /

+ (+0.00%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

CSSE Chicken Soup for the Soul
/

+

07/12/22 B. Riley
Chicken Soup sees positive free cash flow by year-end, says B. Riley
06/14/22 DA Davidson
DA Davidson likes Chicken Soup for the Soul amid strong box office, Redbox deal
05/27/22 B. Riley
Redbox downgraded to Sell from Neutral at B. Riley
05/17/22 Guggenheim
Chicken Soup for the Soul resumed with a Buy at Guggenheim
RDBX Redbox
$1.71 /

+ (+0.00%)

07/12/22 B. Riley
Chicken Soup sees positive free cash flow by year-end, says B. Riley
06/14/22 DA Davidson
DA Davidson likes Chicken Soup for the Soul amid strong box office, Redbox deal
05/27/22 B. Riley
Redbox downgraded to Sell from Neutral at B. Riley
05/17/22 Guggenheim
Chicken Soup for the Soul resumed with a Buy at Guggenheim
ROKU Roku
$80.65 /

-0.33 (-0.41%)

08/10/22 MoffettNathanson
MoffettNathanson downgrades Roku to sell on 'challenged' position
08/10/22 MoffettNathanson
Roku downgraded to Underperform from Market Perform at MoffettNathanson
08/08/22 Pivotal Research
Roku downgraded to Sell from Hold at Pivotal Research
08/03/22 Citi
Roku price target lowered to $125 from $165 at Citi
CSSE Chicken Soup for the Soul
/

+

ROKU Roku
$80.65 /

-0.33 (-0.41%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

CSSE Chicken Soup for the Soul
/

+

RDBX Redbox
$1.71 /

+ (+0.00%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

CSSE Chicken Soup for the Soul
/

+

RDBX Redbox
$1.71 /

+ (+0.00%)

ROKU Roku
$80.65 /

-0.33 (-0.41%)

Downgrade
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
ALGT

Allegiant Travel

$107.03 /

-0.12 (-0.11%)

Wolfe Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

07:00 Today Wolfe Research
Allegiant Travel downgraded to Peer Perform from Outperform at Wolfe Research
08/10/22 Barclays
Allegiant Travel price target lowered to $150 from $180 at Barclays
08/04/22 Deutsche Bank
Allegiant Travel price target lowered to $190 from $245 at Deutsche Bank
07/26/22 Susquehanna
Allegiant Travel negative reveal suggests price sensitivity, says Susquehanna
ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

ALGT Allegiant Travel
$107.03 /

-0.12 (-0.11%)

Hot Stocks
HCW Biologics expects cash to fund operations through end of 2023 » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
HCWB

HCW Biologics

$2.04 /

-0.21 (-9.33%)

On June 30, 2022, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

Earnings
HCW Biologics reports Q2 EPS (66c) vs (10c) last year » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
HCWB

HCW Biologics

$2.04 /

-0.21 (-9.33%)

Reports Q2 revenue $0 vs…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
03/24/22 Maxim
HCW Biologics initiated with a Buy at Maxim
HCWB HCW Biologics
$2.04 /

-0.21 (-9.33%)

Earnings
Silver Spike Investment reports Q1 NII 4c vs. ($425.03) last year » 07:10
08/12/22
08/12
07:10
08/12/22
07:10
SSIC

Silver Spike Investment

$8.86 /

-0.33 (-3.59%)

Net asset value per share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SSIC Silver Spike Investment
$8.86 /

-0.33 (-3.59%)

03/01/22 Piper Sandler
Silver Spike Investment initiated with an Overweight at Piper Sandler
03/01/22 Stifel
Silver Spike Investment initiated with a Hold at Stifel
  • 04
    Feb
Earnings
Instil Bio reports Q2 adjusted EPS (40c), consensus (41c) » 07:08
08/12/22
08/12
07:08
08/12/22
07:08
TIL

Instil Bio

$6.79 /

+0.09 (+1.34%)

As of June 30, 2022, we…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

06/05/22 Morgan Stanley
Instil Bio price target lowered to $9 from $14 at Morgan Stanley
08/13/21 Baird
Baird sees likely success for Instil Bio lead candidate, starts at Outperform
08/12/21 Baird
Instil Bio initiated with an Outperform at Baird
TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

TIL Instil Bio
$6.79 /

+0.09 (+1.34%)

Hot Stocks
Rapid Micro Biosystems adopts stockholder rights plan » 07:08
08/12/22
08/12
07:08
08/12/22
07:08
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Rapid Micro Biosystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Hot Stocks
Rapid Micro Biosystems announces review of strategic alternatives » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

Rapid Micro Biosystems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Recommendations
Marriott Vacations price target lowered to $202 from $205 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
VAC

Marriott Vacations

$146.63 /

+1.64 (+1.13%)

Truist analyst Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

08/10/22 Barclays
Marriott Vacations price target raised to $165 from $136 at Barclays
08/10/22 Deutsche Bank
Marriott Vacations price target raised to $192 from $188 at Deutsche Bank
06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Marriott Vacations initiated with an Overweight at Barclays
VAC Marriott Vacations
$146.63 /

+1.64 (+1.13%)

Recommendations
Travel + Leisure price target lowered to $72 from $78 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
TNL

Travel + Leisure

$45.78 /

+0.795 (+1.77%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNL Travel + Leisure
$45.78 /

+0.795 (+1.77%)

TNL Travel + Leisure
$45.78 /

+0.795 (+1.77%)

08/01/22 Deutsche Bank
Travel + Leisure price target lowered to $69 from $76 at Deutsche Bank
07/28/22 Stifel
Travel + Leisure price target lowered to $61 from $76 at Stifel
06/28/22 Barclays
Travel + Leisure initiated with an Equal Weight at Barclays
04/29/22 Jefferies
Travel + Leisure upgraded to Buy at Jefferies after positive headline results
TNL Travel + Leisure
$45.78 /

+0.795 (+1.77%)

Recommendations
Hilton Grand Vacations price target lowered to $63 from $64 at Truist » 07:07
08/12/22
08/12
07:07
08/12/22
07:07
HGV

Hilton Grand Vacations

$43.49 /

-0.17 (-0.39%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HGV Hilton Grand Vacations
$43.49 /

-0.17 (-0.39%)

HGV Hilton Grand Vacations
$43.49 /

-0.17 (-0.39%)

06/28/22 Barclays
Barclays says shift in preferences to cushion Gaming, Cruises, Timeshare names
06/28/22 Barclays
Hilton Grand Vacations initiated with an Overweight at Barclays
03/08/22 Truist
Hilton Grand Vacations price target raised to $63 from $60 at Truist
12/06/21 Truist
Hilton Grand Vacations price target raised to $60 from $54 at Truist
HGV Hilton Grand Vacations
$43.49 /

-0.17 (-0.39%)

Earnings
Applied Therapeutics reports Q2 EPS (96c), consensus (78c) » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
APLT

Applied Therapeutics

$1.31 /

+0.09 (+7.38%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

04/13/22 Truist
Applied Therapeutics price target lowered to $6 from $85 at Truist
03/21/22 Barclays
Applied Therapeutics price target lowered to $2.50 from $7 at Barclays
01/05/22 Citi
Applied Therapeutics price target lowered to $30 from $38 at Citi
01/04/22 Goldman Sachs
Applied Therapeutics price target lowered to $3 from $10 at Goldman Sachs
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

  • 23
    Jun
APLT Applied Therapeutics
$1.31 /

+0.09 (+7.38%)

Recommendations
Bluegreen Vacations price target lowered to $56 from $57 at Truist » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
BVH

Bluegreen Vacations

$23.67 /

+0.01 (+0.04%)

Truist analyst C. Patrick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

03/08/22 Truist
Bluegreen Vacations price target raised to $56 from $44 at Truist
11/16/21 Truist
Bluegreen Vacations price target raised to $44 from $41 at Truist
11/05/21 B. Riley
Bluegreen Vacations price target raised to $59 from $42.50 at B. Riley
09/29/21 Truist
Bluegreen Vacations Holding assumed with a Buy at Truist
BVH Bluegreen Vacations
$23.67 /

+0.01 (+0.04%)

Hot Stocks
Rapid Micro Biosystems rejects non-binding proposal from Kennedy Lewis » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

In addition, the Company…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Downgrade
TIS Inc. downgraded to Neutral from Buy at Citi » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
TISNF

TIS Inc.

/

+

Citi analyst Mitsunobu…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TISNF TIS Inc.
/

+

05/26/22 Jefferies
TIS Inc. downgraded to Hold from Buy at Jefferies
12/14/21 Daiwa
TIS Inc. upgraded to Outperform from Neutral at Daiwa
10/01/21 Credit Suisse
TIS Inc. downgraded to Neutral from Outperform at Credit Suisse
09/17/21 Daiwa
TIS Inc. downgraded to Neutral from Outperform at Daiwa
Recommendations
System1 price target lowered to $13 from $15 at Benchmark » 07:06
08/12/22
08/12
07:06
08/12/22
07:06
SST

System1

$8.69 /

+0.045 (+0.52%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

07/11/22 BofA
BofA starts System1 at Buy with $12 price target
07/11/22 BofA
System1 initiated with a Buy at BofA
04/26/22 Evercore ISI
System1 initiated with an In Line at Evercore ISI
04/06/22 DA Davidson
System1 price target raised to $26 from $23 at DA Davidson
SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

SST System1
$8.69 /

+0.045 (+0.52%)

Hot Stocks
Iterum Therapeutics expects cash to fund operations into 2024 » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
ITRM

Iterum Therapeutics

$0.25 /

+0.0007 (+0.28%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

Earnings
Iterum Therapeutics reports Q2 adjusted EPS (3c) vs (4c) last year » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
ITRM

Iterum Therapeutics

$0.25 /

+0.0007 (+0.28%)

"We are excited to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

ITRM Iterum Therapeutics
$0.25 /

+0.0007 (+0.28%)

Earnings
Casi Pharmaceuticals reports Q2 EPS (56c), consensus (64c) » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
CASI

Casi Pharmaceuticals

$3.91 /

+0.91 (+30.33%)

Reports Q2 revenue $8.6M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

06/03/22 BTIG
Casi Pharmaceuticals price target adjusted to $21 at BTIG after 1 for 10 split
05/26/22 Oppenheimer
Casi Pharmaceuticals should benefit from Shanghai's reopening, says Oppenheimer
05/13/22 H.C. Wainwright
Casi Pharmaceuticals price target lowered to $3 from $4 at H.C. Wainwright
CASI Casi Pharmaceuticals
$3.91 /

+0.91 (+30.33%)

Hot Stocks
Rapid Micro Biosystems CCO Andy Keys departs » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
RPID

Rapid Micro Biosystems

$4.21 /

-0.03 (-0.71%)

In connection with the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

10/14/21 Cowen
Rapid Micro Biosystems coverage transferred at Cowen
RPID Rapid Micro Biosystems
$4.21 /

-0.03 (-0.71%)

Earnings
Fennec reports Q2 EPS (19c), consensus (14c) » 07:05
08/12/22
08/12
07:05
08/12/22
07:05
FENC

Fennec

$6.99 /

+0.07 (+1.01%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FENC Fennec
$6.99 /

+0.07 (+1.01%)

FENC Fennec
$6.99 /

+0.07 (+1.01%)

08/08/22 Craig-Hallum
Fennec assumed with a Buy at Craig-Hallum
12/01/21 Maxim
Fennec price target lowered to $10 from $12 at Maxim
11/30/21 Craig-Hallum
Fennec price target lowered to $14 from $19 at Craig-Hallum
FENC Fennec
$6.99 /

+0.07 (+1.01%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.